Sakar Healthcare

SAKAR03 May 2024

Pharmaceuticals

₹

-2.90 (-0.83%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Sakar Healthcare

Sakar Healthcare

Pharmaceuticals

SAKAR03 May 2024

₹

-2.90 (-0.83%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
02-Feb-2024	BC	To consider and approve the financial results for the period ended December 31, 2023 Sakar Healthcare Limited has submitted to the Exchange, the financial results for the period ended December 31,	10-Feb-2024
27-Nov-2023	BC	Sakar Healthcare Limited has informed the Exchange regarding Notice of Extraordinary General Meeting to be held on December 20, 2023 Sakar Healthcare Limited has informed the Exchange regarding Pr	20-Dec-2023
16-Nov-2023	BC	To consider Fund Raising and other business matters Sakar Healthcare Limited has informed the Exchange regarding Board meeting held on November 21, 2023. (As Per NSE Announcement Dated on: 21/	21-Nov-2023
05-Oct-2023	BC	SAKAR HEALTHCARE LIMITED has informed the Exchange about Notice of Shareholders Meeting for Postal Ballot Sakar Healthcare Limited has informed the Exchange regarding Proceedings of Postal Ballot.	07-Nov-2023
31-Oct-2023	BC	To consider and approve the financial results for the period ended September 30, 2023 and other business matters Sakar Healthcare Limited has informed the Exchange regarding Board meeting held on	06-Nov-2023

No Rights has been declared by SAKAR

Book Closure

Record Date	Split Date	Purpose
10-Feb-2024	-	To consider and approve the financial results for the period ended December 31, 2023 Sakar Healthcare Limited has submitted to the Exchange, the financial results for the period ended December 31,
20-Dec-2023	-	Sakar Healthcare Limited has informed the Exchange regarding Notice of Extraordinary General Meeting to be held on December 20, 2023 Sakar Healthcare Limited has informed the Exchange regarding Pr
21-Nov-2023	-	To consider Fund Raising and other business matters Sakar Healthcare Limited has informed the Exchange regarding Board meeting held on November 21, 2023. (As Per NSE Announcement Dated on: 21/
07-Nov-2023	-	SAKAR HEALTHCARE LIMITED has informed the Exchange about Notice of Shareholders Meeting for Postal Ballot Sakar Healthcare Limited has informed the Exchange regarding Proceedings of Postal Ballot.
06-Nov-2023	-	To consider and approve the financial results for the period ended September 30, 2023 and other business matters Sakar Healthcare Limited has informed the Exchange regarding Board meeting held on

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Sakar Healthcare Ltd ₹347.90(-2.90/-0.83%)	347.90	-2.90	762.99	63.73	61.11	3.02
Lupin Ltd ₹1,657.75(+10.10/0.61%)	1,657.75	+10.10	75,091.67	132.46	36.44	3.90
Ipca Laboratories Ltd ₹1,333.00(-18.00/-1.33%)	1,333.00	-18.00	34,275.44	90.72	62.23	5.52
J B Chemicals & Pharmaceuticals Ltd ₹1,883.85(-1.75/-0.09%)	1,883.85	-1.75	29,263.53	81.31	57.83	10.91
Sanofi India Ltd ₹8,555.00(-122.75/-1.41%)	8,555.00	-122.75	19,984.86	59.90	33.85	19.68
IOL Chemicals & Pharmaceuticals Ltd ₹388.55(-3.75/-0.96%)	388.55	-3.75	2,303.02	-4.21	13.36	1.45

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	37.23	34.08	38.99	40.65	33.47	30.71
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	37.23	34.08	38.99	40.65	33.47	30.71
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.23	0.66	1.52	1.82	1.85	0.60
Total Income	37.46	34.74	40.51	42.47	35.32	31.30
Total Expenditure	28.22	24.72	29.96	32.87	24.67	22.11
PBIDT	9.24	10.02	10.55	9.60	10.65	9.20
Interest	1.79	1.65	2.08	2.15	1.94	0.99
PBDT	7.45	8.37	8.47	7.44	8.71	8.20
Depreciation	4.44	4.22	4.52	3.55	4.10	3.77
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.93	0.52	1.11	-0.03	0.60	2.49
Reported Profit After Tax	2.07	3.64	2.84	3.92	4.01	1.94
Extra-ordinary Items	0.00	0.00	0.00	-0.01	0.00	0.00
Adjusted Profit After Extra-ordinary item	2.07	3.64	2.84	3.93	4.01	1.94

EPS (Unit Curr.)	0.98	1.68	1.46	2.04	2.16	1.01
EPS (Adj) (Unit Curr.)	0.98	1.68	1.46	2.04	2.16	1.01
Calculated EPS (Unit Curr.)	0.95	1.70	1.49	2.06	2.16	1.04
Calculated EPS (Adj) (Unit Curr.)	0.95	1.70	1.49	2.06	2.16	1.04
Calculated EPS (Ann.) (Unit Curr.)	3.81	6.81	5.97	8.24	8.62	4.18
Calculated EPS (Adj) (Ann.) (Unit Curr.)	3.81	6.81	5.97	8.24	8.62	4.18
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	21.75	21.35	19.04	19.04	18.62	18.62
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	24.82	29.40	27.06	23.62	31.82	29.96
PBDTM(%)	20.01	24.56	21.72	18.30	26.02	26.70
PATM(%)	5.56	10.68	7.28	9.64	11.98	6.32

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	37.23	34.08	38.99	40.65	33.47	30.71
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	37.23	34.08	38.99	40.65	33.47	30.71
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.23	0.66	1.52	1.82	1.85	0.60
Total Income	37.46	34.74	40.51	42.47	35.32	31.30
Total Expenditure	28.22	24.72	29.96	32.87	24.67	22.11
PBIDT	9.24	10.02	10.55	9.60	10.65	9.20
Interest	1.79	1.65	2.08	2.15	1.94	0.99
PBDT	7.45	8.37	8.47	7.44	8.71	8.20
Depreciation	4.44	4.22	4.52	3.55	4.10	3.77
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.93	0.52	1.11	-0.03	0.60	2.49
Reported Profit After Tax	2.07	3.64	2.84	3.92	4.01	1.94
Minority Interest After NP	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit after Minority Interest	2.07	3.64	2.84	3.92	4.01	1.94

Extra-ordinary Items	0.00	0.00	0.00	-0.01	0.00	0.00
Adjusted Profit After Extra-ordinary item	2.07	3.64	2.84	3.93	4.01	1.94

EPS (Unit Curr.)	0.98	1.68	1.46	2.04	2.16	1.01
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	21.75	21.35	19.04	19.04	18.62	18.62

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	24.82	29.40	27.06	23.62	31.82	29.96
PBDTM(%)	20.01	24.56	21.72	18.30	26.02	26.70
PATM(%)	5.56	10.68	7.28	9.64	11.98	6.32

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	19.04	17.12	15.62	14.96	14.96	12.21
Reserves Total	154.39	110.42	82.84	66.36	56.77	34.61
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	4.68
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	173.43	127.54	98.46	81.32	71.73	51.50
Secured Loans	93.17	79.93	35.04	8.79	1.57	6.06
Unsecured Loans	26.00	12.93	7.56	7.91	9.54	5.15
Total Debt	119.17	92.86	42.60	16.70	11.11	11.21
Total Liabilities	292.60	220.40	141.06	98.02	82.84	62.71
APPLICATION OF FUNDS :
Gross Block	304.98	228.02	90.27	78.81	69.58	76.47
Less : Accumulated Depreciation	38.34	23.36	21.18	13.12	6.04	23.14
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	266.64	204.66	69.09	65.69	63.54	53.33
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	6.45	1.23	48.92	13.10	8.66	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	3.44	7.12	0.01	0.01	0.00	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	15.40	14.18	15.70	10.93	6.86	3.93
Sundry Debtors	22.08	14.18	12.37	8.23	9.50	10.82
Cash and Bank	0.09	0.03	0.08	0.30	0.37	0.36
Loans and Advances	15.00	14.60	5.64	2.18	3.33	12.31
Total Current Assets	52.56	43.00	33.80	21.65	20.05	27.42
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	31.73	35.73	26.15	8.46	5.95	10.24
Provisions	1.80	3.19	2.97	1.55	2.04	1.17
Total Current Liabilities	33.54	38.92	29.13	10.01	7.99	11.42
Net Current Assets	19.03	4.08	4.67	11.63	12.07	16.00
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	7.36	0.41	0.67	0.90	1.20	0.00
Deferred Tax Liability	15.94	7.51	7.49	7.29	7.27	6.98
Net Deferred Tax	-8.58	-7.10	-6.82	-6.39	-6.07	-6.98
Total Assets	286.98	209.98	115.88	84.03	78.20	62.35
Contingent Liabilities	0.00	0.00	0.00	0.00	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	0.03	0.08	0.30	0.37	0.36
Net Cash from Operating Activities	33.34	35.79	14.58	18.79	16.14
Net Cash Used In Investing Activities	-74.38	-90.40	-46.83	-22.34	-24.91
Net Cash Used In Financing Activities	41.10	54.56	32.03	3.48	8.77
Net Inc./Dec In Cash And Cash Equivalents	0.06	-0.05	-0.22	-0.07	0.00
Cash And Cash Equivalents At End Of The Year	0.09	0.03	0.08	0.30	0.37

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

53.15%

FII Shareholding

13.52%

DII Shareholding

10.62%

Public Shareholding

22.71%

**Promoter pledged shareholding 53.15%

About Sakar Healthcare Ltd

Sakar Healthcare Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 762.99 crores. It has reported a sales of Rs. 37.23 crores and a net profit of Rs. 2.07 crores for the quarter ended December 2018. The company management includes Sanjay S Shah., Sanjay S Shah.,Aarsh S Shah,Ritaben S Shah,Shailesh B Patel,Prashant C Srivastav,Hemendrakumar C Shah (Sakar Healthcare Ltd) among others.

Chairman

Sanjay S Shah.

Registered office

10/13 Nr MN Desai Petrol Pump,Sarkhej Bavla Highway,Changodar,Gujarat,382213

FAX :91-2717-251621

Background

Incorporation Year2004

Face Value₹10

Market Lot1

How to buy Sakar Healthcare shares on nse?

To buy Sakar Healthcare shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Sakar Healthcare share price today?

The Sakar Healthcare shares price on nse is Rs.347.9 today.

What is the market cap of Sakar Healthcare shares on NSE ?

The company has a market capitalization of Rs.762.99Cr

What is the PE & PB ratio of Sakar Healthcare shares ?

PE is 61.11 and PB is 3.02

What is the 52 Week High and Low of Sakar Healthcare shares?

Sakar Healthcare stock price high: Rs.479 Sakar Healthcare stock price low: Rs.211.2